Cipta Sarana Medika Tbk. vs Surya Fajar Capital Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp64 (market cap 163.22B, 3.92M 24h volume), while Surya Fajar Capital Tbk. trades at Rp2,010 (market cap 2.73T, 42K 24h volume). The key difference: Surya Fajar Capital Tbk. is far larger — about 16.7× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (3.92M versus 42K). Which is the better fit depends on your goals.
| DKHH | SFAN | |
|---|---|---|
Market Cap | 163.22B | 2.73T |
Volume | 3.92M | 42K |
Lot | 39.16K | 420 |
Turnover | 249.6M | 84.02M |
Average Price | 63.74 | 2,000.55 |
Value | 249.6M | 84.02M |
Indicative Equilibrium Price | 64 | 2,010 |
Indicative Equilibrium Volume | 77 | 300 |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Surya Fajar Capital Tbk (the Company) was established based on Notarial Deed No. 12 dated April 5, 2016 of Humberg Lie, S.H., S.E., M.Kn., a public notary in North Jakarta.
Read more on SFAN →